CIPLA Trademark

Trademark Overview


On Friday, October 26, 2018, a trademark application was filed for CIPLA with the United States Patent and Trademark Office. The USPTO has given the CIPLA trademark a serial number of 88171179. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2019. This trademark is owned by CIPLA LIMITED. The CIPLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures Huntington's disease, multiple sclerosis; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, namely, Coronary artery disease, Heart attack, abnormal heart rhythms, arrhythmias, heart failure, heart valve disease, congenital heart disease, cardiomyopathy, pericardial disease; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of migraines and other forms of headache, namely, sinus headaches, tension headaches, cluster headaches and rebound headaches; pharmaceutical and medicinal preparations, namely, analgesics; pharmaceutical and medicinal preparations, namely,...
cipla

General Information


Serial Number88171179
Word MarkCIPLA
Filing DateFriday, October 26, 2018
Status700 - REGISTERED
Status DateTuesday, October 29, 2019
Registration Number5894625
Registration DateTuesday, October 29, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements


Goods and ServicesPharmaceutical and medicinal preparations for the treatment, alleviation and prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures Huntington's disease, multiple sclerosis; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, namely, Coronary artery disease, Heart attack, abnormal heart rhythms, arrhythmias, heart failure, heart valve disease, congenital heart disease, cardiomyopathy, pericardial disease; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of migraines and other forms of headache, namely, sinus headaches, tension headaches, cluster headaches and rebound headaches; pharmaceutical and medicinal preparations, namely, analgesics; pharmaceutical and medicinal preparations, namely, antiviral and anti-retroviral pharmaceutical preparations for the treatment of viral brain diseases; pharmaceutical and medicinal preparations, namely, anti-infectives; pharmaceutical and medicinal preparations, namely, anti-inflammatories; pharmaceutical and medicinal preparations, namely, antibiotics; pharmaceutical and medicinal preparations, namely, antidepressants; pharmaceutical and medicinal preparations, namely, anti-cancer preparations; pharmaceutical and medicinal preparations, namely, medicated soaps and lotions for the skin and hair, namely, medicated acne lotion, medicated body moisturizing lotion, medicated lotion for eczema and seborrheic dermatitis, medicated hair shampoo and hair scalp lotion, medicated anti-dandruff lotion; pharmaceutical and medicinal preparations, namely, decongestants and antihistamines; pharmaceutical and medicinal preparations, namely, scabicides; pharmaceutical and medicinal preparations, namely, anti-malarials; pharmaceutical and medicinal preparations, namely, cough suppressants; pharmaceutical and medicinal preparations, namely, cough and cold preparations; pharmaceutical and medicinal preparations, namely, expectorants; pharmaceutical and medicinal preparations, namely, anti-leukemic agents; pharmaceutical and medicinal preparations, namely, tissue sealants; pharmaceutical and medicinal preparations, namely, vasopressors; pharmaceutical and medicinal preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; pharmaceutical and medicinal preparations, namely, preparations for the treatment of gout; pharmaceutical and medicinal preparations, namely, preparations for cessation of smoking; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of genitourinary diseases and disorders, namely, urological diseases, urological disorders, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of pain from burns, hemolytic diseases and disorders, neuropathic pain; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of fibromyalgia, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely, herpes, hepatitis, substance abuse disorders, namely, alcoholism and drug addiction, carpel tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and, restless leg syndrome, premature ejaculation, macular degeneration, thrombosis and thromboembolism; pharmaceutical and medicinal preparations, namely, vaccines for human use; pharmaceutical and medicinal preparations, namely, adjuvants for use with human vaccines; pharmaceutical and medicinal preparations in the nature of veterinary preparations, namely, flea and tick preparations, vaccines, anti inflammatories, mastitis preparations, and oncological preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCIPLA LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN

Party NameCIPLA LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN

Party NameCIPLA LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN

Trademark Events


Event DateEvent Description
Tuesday, October 29, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 8, 2019ASSIGNED TO LIE
Thursday, June 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 27, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, June 27, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 27, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, June 27, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, June 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 4, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 4, 2019NON-FINAL ACTION E-MAILED
Monday, February 4, 2019NON-FINAL ACTION WRITTEN
Monday, February 4, 2019ASSIGNED TO EXAMINER
Friday, November 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 30, 2018NEW APPLICATION ENTERED IN TRAM